[Functional implications of single nucleotide polymorphisms (SNPs) in protein-coding and non-coding RNA genes in
Julián Ramírez-Bello1, Mayra Jiménez-Morales1
1Unidad de Investigación en Enfermedades y Metabólicas, Hospital Juárez de México, Ciudad de México, México.
Summary
Single nucleotide polymorphisms (SNPs) are common genetic variations. Functional SNPs in coding and non-coding RNA genes significantly impact biological processes and multifactorial diseases.
Area of Science:
- Genetics
- Molecular Biology
- Genomics
Background:
- Single nucleotide polymorphisms (SNPs) are the most frequent human genome variations.
- SNPs can be neutral, having no effect, or functional, influencing biological processes and disease risk.
- Functional SNPs are crucial for understanding multifactorial diseases.
Purpose of the Study:
- To review the functional roles of SNPs in protein-coding and non-coding RNA genes.
- To elucidate the relationship between these SNPs and multifactorial diseases.
- To update readers on recent findings in SNP functional characterization.
Main Methods:
- Classification of SNPs based on their location (protein-coding vs. non-coding RNA genes) and effect (neutral vs. functional).
- Categorization of functional SNPs into regulatory SNPs (rSNPs) and structural RNA SNPs (srSNPs), including microRNA-related variants (miR-rSNPs, miR-srSNPs).
- Analysis of SNP impact on gene expression, RNA splicing, translation, stability, protein structure/function, and miRNA-mRNA interactions.
Main Results:
- Regulatory SNPs (rSNPs) in gene promoters affect gene expression.
- Structural RNA SNPs (srSNPs) impact RNA processing, protein attributes, and molecular interactions.
- MicroRNA-related SNPs (miR-rSNPs, miR-srSNPs) influence miRNA processing, structure, and target interactions.
- Functional characterization of risk alleles aids in understanding complex disease mechanisms.
Conclusions:
- Functional SNPs in coding and non-coding RNAs play significant roles in multifactorial diseases.
- Understanding SNP function is key to unraveling disease etiology.
- This review provides an updated perspective on the functional impact of SNPs in health and disease.
Related Concept Videos
Translation
20.4K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
20.4K
Translation
158.4K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
158.4K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
65
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
65
Principles of Pharmacogenetics: Types of Genetic Variants
60
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
60
RNA Splicing
61.0K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.0K
Single Nucleotide Polymorphisms-SNPs
18.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.8K


